Drug intelligence / Profile preview

baicalin

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Baicalin is a flavone glycoside and a major bioactive flavonoid found in several species of the genus Scutellaria (notably Scutellaria baicalensis), as well as in Oroxylum indicum. Chemically it is the glucuronide of baicalein. Baicalin acts as a positive allosteric modulator at the benzodiazepine site and/or non-benzodiazepine site of the GABAA receptor and produces anxiolytic effects without sedative or myorelaxant properties in animal models. It also functions as an inhibitor of prolyl endopeptidase. Pharmacologically, it has demonstrated antioxidant, anti-inflammatory, anti-tumor (including induction of apoptosis and cell cycle arrest), neuroprotective (notably in cerebral ischemia), antiviral (anti-HIV), and immunomodulatory activities. Baicalin is used primarily in traditional Chinese medicine formulations such as Shuanghuanglian and Sho-Saiko-To/Kampo medicine for various inflammatory conditions[1][3][6][9].

Other names
baicalinbaikalinbaicalein 7-O-glucuronidebaicalein7-O-glucuronidebaicalein-7-O-glucuronidebaicalein 7-glucuronidebaicalein7-glucuronidebaicalein-7-glucuronide7-D-glucuronic acid-5,6-dihydroxyflavoneBaicalein-7-D-glucuronideBaicalein7-D-glucuronideBaicalein 7-D-glucuronideHuang qin
02

Targets

GABRR (GABA-A receptor subunit rho)PREP (Prolyl Oligopeptidase)

Beyond the preview

Go deeper on baicalin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on baicalin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call